# Combined Liraglutide and Metformin Therapy in Women With Previous Gestational Diabetes Mellitus (GDM)

Study · id `cardio:ct-nct01234649` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01234649](<https://clinicaltrials.gov/study/NCT01234649>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01234649

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 153 participants.

## Technical summary

Registry record NCT01234649. Randomized; triple masking; primary purpose prevention. Start 2011-08-11 (actual); primary completion 2019-04-24 (actual). Results posted on 2019-07-26.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose prevention
- Phase: Phase 3
- Enrolled: 153 participants (enrolled count; ClinicalTrials.gov record NCT01234649, source copy `cardio:ctgov-nct01234649-2019-07-26`, retrieved 2026-10-26)
- Started: 2011-08-11 (actual) (ClinicalTrials.gov record NCT01234649, source copy `cardio:ctgov-nct01234649-2019-07-26`, retrieved 2026-10-26)
- Primary completion: 2019-04-24 (actual) (ClinicalTrials.gov record NCT01234649, source copy `cardio:ctgov-nct01234649-2019-07-26`, retrieved 2026-10-26)
- Completion: 2019-06-14 (actual) (ClinicalTrials.gov record NCT01234649, source copy `cardio:ctgov-nct01234649-2019-07-26`, retrieved 2026-10-26)
- Results first posted: 2019-07-26 (ClinicalTrials.gov record NCT01234649, source copy `cardio:ctgov-nct01234649-2019-07-26`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT01234649, source copy `cardio:ctgov-nct01234649-2019-07-26`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01234649-2019-07-26`, retrieved 2026-10-26)

## The registry's words

- Brief title: Combined Liraglutide and Metformin Therapy in Women With Previous Gestational Diabetes Mellitus (GDM)
- Condition: Gestational Diabetes Mellitus
- Condition: Type 2 Diabetes Mellitus
- Condition: Metabolic Syndrome
- Condition: Impaired Glucose Tolerance
- Condition: Disorder of Glucose Regulation
- Intervention (Drug): Metformin XR plus placebo
- Intervention (Drug): Metformin XR plus liraglutide
- Lead sponsor: Woman's
- Lead sponsor class: OTHER
- Collaborator: Novo Nordisk A/S
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)
- Registry lists this organization as a collaborator: Novo Nordisk (`cardio:novo-nordisk`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Postpartum treatment with liraglutide in combination with metformin versus metformin monotherapy to improve metabolic status and reduce body weight in overweight/obese women with recent gestational diabetes: A double-blind, randomized, placebo-controlled study (`cardio:pubmed-32046931`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 447687caaaae4a7ac967bd8f743c18ae668fef34893836838995f007db87c9ec
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
